Best VPN for Android 2025: NordVPN Voted Best of VPNs for Android
WiFi Profits Under Review: How to Get Dumb Money with Wireless
insightsoftware Launches Spreadsheet Server Integration with Infor M3 Cloud, Accelerating Self-Service Reporting in Excel
Hyper Bit Joins American Blockchain & Cryptocurrency Association
Syntheia Signs Non-Binding LOI for Call Center Acquisition
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…
VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / Sassy Resources Corporation (“Sassy” or the…
VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / BTU METALS CORP. (“BTU” or the…
PERTH, AUSTRALIA / ACCESSWIRE / May 14, 2021 / Tempus Resources Ltd (“Tempus” or the…
LONDON, UK / ACCESSWIRE / May 14, 2021 / The Forex market is one of…
VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / Hannan Metals Limited (“Hannan” or the…
DALTON, GA / ACCESSWIRE / May 14, 2021 / You are invited to participate in…
VILNIUS, LITHUANIA / ACCESSWIRE / May 14, 2021 / Trend Innovations Holding Inc. (OTC PINK:TREN),…
MIAMI, FL / ACCESSWIRE / May 14, 2021 / For projects that exceed 1 million dollars…
VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / Gold Mountain Mining Corp. (“Gold Mountain”…
LISBON, PORTUGAL / ACCESSWIRE / May 14, 2021 / Exeedme, a Portugal-based gaming company, has…
Maker of world’s first multi-mode smartphones details tech roadmap and commercial plan NEW YORK, NY…
5G, Open RAN and Neutral Host feature heavily as awards recognise companies looking to the…
Data presented at the 2021 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting…
Japanese Marketing Authorization Application (J-MAA) for efgartigimod accepted for review by Japan’s Pharmaceuticals and Medical…
Geneva, Switzerland, May 14, 2021 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage…
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
TORRANCE, May 13, 2021 (GLOBE NEWSWIRE) — Premier Information Management, Inc. (OTC: PIFR) announced today…
– Established cGMP manufacturing and development agreement with Catalent for otoferlin dual-vector gene therapy, DB-OTO –…
First Patient Dosed in Validive® Phase 2b/3 VOICE Clinical TrialCamsirubicin Run-in Clinical Trial Now Planned…